BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4906733)

  • 1. Anti-neuroglial and anti-neuronal cell factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Bornstein MB
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:574-607. PubMed ID: 4906733
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental allergic encephalomyelitis: a light and electron microscope study of remyelination and "sclerosis" in vitro.
    Raine CS; Bornstein MB
    J Neuropathol Exp Neurol; 1970 Oct; 29(4):552-74. PubMed ID: 5471921
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental allergic encephalomyelitis: serum immunoglobulin binds to myelin and oligodendrocytes in cultured tissue: ultrastructural-immunoperoxidase observations.
    Johnson AB; Raine CS; Bornstein MB
    Lab Invest; 1979 May; 40(5):568-75. PubMed ID: 374865
    [No Abstract]   [Full Text] [Related]  

  • 7. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
    Bartlett PF; Mackay IR
    J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.
    Prineas J; Raine CS; Wísniewski H
    Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis.
    Okuda Y; Sakoda S; Fujimura H; Nagata S; Yanagihara T; Bernard CC
    Biochem Biophys Res Commun; 2000 Aug; 275(1):164-8. PubMed ID: 10944459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S; Martin R
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental allergic encephalomyelitis: demyelination, remyelination and sclerosis in cultured mammalian CNS tissue.
    Bornstein MB; Raine CS
    Trans Am Neurol Assoc; 1969; 94():46-7. PubMed ID: 5374489
    [No Abstract]   [Full Text] [Related]  

  • 15. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from autoimmunity by DNA vaccination against T-cell receptor.
    Buch T; Waisman A
    Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory disease: assault on the guardian.
    Ransohoff RM
    Nature; 2007 Jul; 448(7152):421-2. PubMed ID: 17653181
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
    Petry KG; Boullerne AI; Pousset F; Brochet B; Caillé JM; Dousset V
    Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroglia and the myelin-bearing cell: a symposium. Immunological factors in experimental allergic encephalomyelitis and multiple sclerosis as revealed by cultures of mammalian nerve tissue.
    Bornstein MB
    J Neurol Neurosurg Psychiatry; 1969 Apr; 32(2):163-4. PubMed ID: 4306415
    [No Abstract]   [Full Text] [Related]  

  • 20. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.